Ovid Therapeutics
OVID
OVID
79 hedge funds and large institutions have $161M invested in Ovid Therapeutics in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
+22
Holders Change %
+38.6%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
39
Increased
18
Reduced
17
Closed
17
Calls
$768K
Puts
$434K
Net Calls
+$334K
Net Calls Change
+$334K
Top Buyers
| 1 |
BlackRock
New York
|
+$17.9M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$8.15M |
| 3 |
State Street
Boston,
Massachusetts
|
+$5.42M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$4.98M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$3.21M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.24M |
| 2 |
CA
CHI Advisors
New York
|
-$2.09M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.74M |
| 4 |
Renaissance Technologies
New York
|
-$1.69M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.13M |
